...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The American journal of cosmetic surgery: journal of the American Society of Cosmetic Surgeons [and] official publication of the American Society of Lipo-Suction Surgery >Long-term Follow-up Study of Intravascular 1320-nm Laser Closure of the Great Saphenous Vein
【24h】

Long-term Follow-up Study of Intravascular 1320-nm Laser Closure of the Great Saphenous Vein

机译：大隐静脉血管内1320 nm激光闭合的长期随访研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: To determine the long-term efficacy and safety of a 1320-nm intravascular laser to close the great saphenous vein (GSV). Methods: Sixty-four patients with incompetent GSV (0.5? 1.44 cm in diameter) associated with distal varicose veins were treated using a 1320-nm intravascular laser at 5-6 W with an automatic pullback mechanism at 1 mm/s. Duplex ultrasound examinations were performed at baseline and patients were followed 1 to 5 years posttreatment. Participants: Of the 64 patients, 84% were women and the average age of the participants was 49 years. Results: The average baseline GSV measured 0.78 cm (range, 0.37-1.95 cm). The average length of follow-up was 25.3 months. A total of 12.5% (8/64) of patients received follow-up sclerotherapy for residual reticular and telangiec-tatic veins. Seventy-five percent (52/64) of patients had absent GSV after treatment. Twenty-five percent (12/64) of patients had open, patent GSV with no reflux. The failure rate for treatment was 7.8% (5/64). Treatment failures included open GSV with reflux, 2 patients who underwent repeat cool touch endovenous laser treatment, and 1 patient who had ultrasound-guided foam sclerotherapy treatment. Conclusions: The 1320-nm intravascular laser is safe and effective in treating an incompetent GSV up to 1.44 cm in diameter.
机译：目的：确定1320 nm血管内激光闭合大隐静脉（GSV）的长期疗效和安全性。方法：使用1320 nm血管内激光以5-6 W的功率通过自动回退机制以1 mm / s的速度治疗64例远端静脉曲张不全的GSV（直径0.5？1.44 cm）的患者。在基线时进行双工超声检查，并在治疗后1至5年对患者进行随访。参与者：在64位患者中，女性占84％，参与者的平均年龄为49岁。结果：平均基线GSV测得0.78厘米（范围0.37-1.95厘米）。平均随访时间为25.3个月。总共12.5％（8/64）的患者接受了残余硬化的网状和毛细血管的硬化治疗。治疗后有百分之七十五（52/64）的患者没有GSV。 25％（12/64）的患者患有开放性GSV专利，无反流。治疗失败率为7.8％（5/64）。治疗失败包括开放性GSV伴反流，2例接受反复冷触静脉激光治疗的患者和1例接受超声引导的泡沫硬化治疗的患者。结论：1320 nm血管内激光治疗直径达1.44 cm的无功能GSV是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号